Dyne Therapeutics, Inc. (DYN) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Dyne Therapeutics, Inc. in 2026. The next earnings report is expected on October 29, 2026.
Next earnings date
29 Oct 2026
In 69 days
EPS estimate
-0.76
Revenue estimate
0
Past earnings
Latest earnings analysis
Dyne Therapeutics missed consensus estimates in its latest earnings report, with EPS of USD -1.08 falling short of the USD -0.7488 estimate while revenue met expectations at USD 0. In the prior report, EPS was ahead of expectations while revenue met estimates.
No dividend history available.
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Dyne Therapeutics, Inc. (DYN) is scheduled to report earnings on October 29, 2026.
Dyne Therapeutics, Inc. (DYN) last reported earnings on July 29, 2026.
Dyne Therapeutics, Inc. (DYN) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.